INSYNC III/II MARQUIS/INSYNC SENTRY/MAXIMO ICDS
FDA premarket approval P010031/S215 · decided 2010-10-15
Approval details
- PMA number
- P010031
- Supplement
- S215
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- INSYNC III/II MARQUIS/INSYNC SENTRY/MAXIMO ICDS
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2010-09-14
- Decision date
- 2010-10-15
- Days to decision
- 31 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- CHANGE TO THE EFTE COATING INSPECTION PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.